John G. McCutcheon
PRESIDENT & CEO
John has 27 years of sales, marketing, and general management experience in medical devices. John started his career at American Hospital Supply (acquired by Baxter International) and has spent the past 20 years at start-ups, including DVI (acquired by Eli Lily), Perclose (acquired by Abbott Laboratories), Emphasys Medical (acquired by Pulmonx) and Ventus Medical. He has served on numerous Boards including Emphasys Medical, Ventus Medical, Disc Dynamics, Zeltiq (ZLTQ), Advanced Stent Technologies (acquired by Boston Scientific) and LuMend (acquired by Johnson & Johnson). John holds B.A. degrees in Economics and Psychology from the University of California, Los Angeles and an M.B.A. from the UCLA Anderson Graduate School of Management.
VP of Research & Development and Manufacturing
Michael has over 15 years of engineering and product development experience. Prior to joining Ceterix, Michael was Vice President of R&D at The Foundry, NewCo XI. He was Director of R&D at Emphasys Medical, R&D Manager at Cardica, Inc., and Mechanical Design Engineer at IDEO. Michael is a co-inventor on over 50 issued and pending U.S. patents. He received an MS in Mechanical Engineering from Stanford University and a BS in Mechanical Engineering from Northwestern University.
VP of Regulatory and Quality AFfairs and Chief Compliance Officer
Scott has over 20 years of experience providing quality and regulatory support for medical device, IVD and biologics manufacturing operations. His extensive quality and regulatory experience prior to joining Ceterix includes leadership roles at Intuitive Surgical, Kyphon and XDx Molecular Diagnostics. He successfully managed the 510(k) submission for the NovoStitch Plus Meniscal Repair System® which received FDA clearance in July of 2015. In addition, Scott has broad knowledge of quality systems and compliance and has been responsible for leading implementation of efficient quality assurance and compliance programs to support development and manufacturing at startup, midsize and large companies. He has routinely served as a principal host for FDA, Notified Body, MAH/MHLW, CA FDB, UL Brazil and other regional regulatory audits and inspections. Scott earned his BS in Biology from James Madison University.
VP OF Human Resources
Patty has over 15 years of experience in all aspects of Human Resources in the life science industry with a passion for building diverse teams at both private and public companies. Prior to joining Ceterix, Patty held various leadership roles with small and mid-size companies including Revance Therapeutics, Ventus Medical, FoxHollow Technologies (acquired by EV3) and Coulter Pharmaceutical (acquired by Corixa). Patty received a B.S. in Management from Golden Gate University in San Francisco and is a certified Professional in Human Resources (PHR).
VP OF MARKETING AND CLINICAL RESEARCH
Chris has over 15 years of marketing and management experience. Before joining Ceterix, Chris was Director of Marketing at Ardian (acquired by Medtronic). Chris began his career at Guidant (acquired by Abbott) and has also spent time at Johnson and Johnson, Medtronic, Conor Medsystems (acquired by Johnson and Johnson) and in strategy consulting. He received his BS and MS in Mechanical Engineering from the University of California at Berkeley and his MBA from the Kellogg School of Management at Northwestern University.
Chief Medical Officer
Dr. Justin Saliman practices orthopaedic surgery with a sports focus at Cedars-Sinai Hospital in Los Angeles. He founded and ran the incubator Revolutionary Surgical Device, LLC in late 2007 which went on to create SuturePro Technologies, LLC and Advanced Meniscus Technologies, LLC in 2009. These companies were merged in 2010 to form Ceterix Orthopaedics. Justin completed medical school at the University of Colorado School of Medicine in his hometown of Denver. He completed his residency in orthopaedic surgery at St. Lukes – Roosevelt Hospital center of Columbia University in New York City and a sports fellowship at Stanford University in Palo Alto.